Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Lixte Biotechnology Holdings Inc

+ Add to Watchlist

LIXT:US

0.2600 USD 0.0600 30.00%

As of 20:10:01 ET on 04/15/2015.

Snapshot for Lixte Biotechnology Holdings Inc (LIXT)

Open: 0.2600 Day's Range: 0.2600 - 0.2600 Volume: 7,300
Previous Close: 0.2000 52wk Range: 0.0700 - 0.5500 1-Yr Rtn: -

Stock Chart for LIXT

No chart data available.
  • LIXT:US 0.2600
  • 1D
  • 1M
  • 1Y
0.2000
Interactive LIXT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LIXT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0600
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 11.85
Shares Outstanding (M) 45.58
30 Day Average Volume 10,693
Price/Book (mrq) 44.4802
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LIXT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LIXT

Lixte Biotechnology Holdings Inc. develops tests for the early detection of cancers. The Company's initial focus is on developing new treatments for the most common and most aggressive type of primary brain cancer, glioblastoma multiforme ("GBM").

John S KovachChairman/Pres/CEO/CFO/Founder
More Company Profile & Key Executives for LIXT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil